- Home
- LASR vs ORIC Comparison
LASR vs ORIC Comparison
Compare LASR & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LASR
- ORIC
- Stock Information
- Founded
- LASR 2000
- ORIC 2014
- Country
- LASR United States
- ORIC United States
- Employees
- LASR N/A
- ORIC N/A
- Industry
- LASR Semiconductors
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- LASR Technology
- ORIC Health Care
- Exchange
- LASR Nasdaq
- ORIC Nasdaq
- Market Cap
- LASR 412.8M
- ORIC 362.9M
- IPO Year
- LASR 2018
- ORIC 2020
- Fundamental
- Price
- LASR $15.13
- ORIC $8.17
- Analyst Decision
- LASR Strong Buy
- ORIC Strong Buy
- Analyst Count
- LASR 4
- ORIC 8
- Target Price
- LASR $16.13
- ORIC $18.83
- AVG Volume (30 Days)
- LASR 769.4K
- ORIC 1.6M
- Earning Date
- LASR 05-08-2025
- ORIC 05-05-2025
- Dividend Yield
- LASR N/A
- ORIC N/A
- EPS Growth
- LASR N/A
- ORIC N/A
- EPS
- LASR N/A
- ORIC N/A
- Revenue
- LASR $205,689,000.00
- ORIC N/A
- Revenue This Year
- LASR $12.44
- ORIC N/A
- Revenue Next Year
- LASR $9.03
- ORIC N/A
- P/E Ratio
- LASR N/A
- ORIC N/A
- Revenue Growth
- LASR 2.66
- ORIC N/A
- 52 Week Low
- LASR $6.20
- ORIC $3.90
- 52 Week High
- LASR $16.21
- ORIC $14.67
- Technical
- Relative Strength Index (RSI)
- LASR 76.31
- ORIC 72.38
- Support Level
- LASR $12.17
- ORIC $5.52
- Resistance Level
- LASR $16.21
- ORIC $8.44
- Average True Range (ATR)
- LASR 0.84
- ORIC 0.63
- MACD
- LASR 0.23
- ORIC 0.32
- Stochastic Oscillator
- LASR 73.83
- ORIC 93.11
About LASR nLIGHT Inc.
nLight Inc is a United States-based company provider of power semiconductor and fiber lasers for aerospace and defense, industrial, and microfabrication applications. It designs, manufactures, and sells a range of power semiconductor lasers and fiber lasers that are typically integrated into laser systems. It operates in two segments: Laser Products, which includes semiconductor lasers, fiber lasers, and directed energy products; and Development segment includes revenue earned from research and development contracts. The majority of its revenue is generated from the Laser segment. The company's geographical segments include North America, Asia Pacific, and EMEA.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.